
到 2028 年南美洲肝癌诊断市场预测 - COVID-19 影响和分析 - 按类型(实验室测试、内窥镜检查、成像、活检等)和最终用户(医院和诊断实验室、学术和研究机构、和 CRO 实验室)
No. of Pages: 129 | Report Code: BMIRE00025044 | Category: Life Sciences
No. of Pages: 129 | Report Code: BMIRE00025044 | Category: Life Sciences
成人肝癌有多种类型,最常见的两种类型是肝细胞癌(HCC)和肝内胆管癌(ICC)。 HCC 是成人中最常见的肝癌形式,ICC 是一种发生在肝脏内部分胆管的肝癌。三维重建图像处理技术的不断进步,将肝脏二维图像数据转化为三维立体模型,并通过3D打印技术将三维重建图像恢复为真实的物理模型。
  ;
此外,通过计算机生成的 3D 可视化或 3D 打印建模,现在可以更准确、更详细地直观地展示肝内动脉的变化等综合信息。此外,由于 3D 可视化或 3D 打印建模,手术导航的肝脏体积计算得到了极大的改进,可以对肝血管进行详细分类,并进行肝脏分割(称为 Fang 分割),用于诊断和治疗原发性肝癌。 p>
此外,由于近几十年来计算机科学特别是人工智能(AI)的快速发展,机器学习、深度学习、大数据等概念不断涌现。数据在很多方面都有应用。基于人工神经网络的深度学习拓展了人工智能在医疗领域的应用范围。深度学习的放射组学研究是目前最热门的研究领域之一。通过放射组学对肝病进行研究将有助于肝病的早期诊断和治疗,提高肝病的生存率和治愈率。因此,新技术的不断出现预计将在预测期内提振市场。
借助新功能和技术,供应商可以吸引新客户并扩大其足迹在新兴市场。这一因素可能会在预测期内推动南美肝癌诊断市场实现大幅复合年增长率。
南美肝癌诊断市场根据类型、最终用户、和国家。根据类型,市场分为实验室测试、成像、内窥镜检查、活检等。 2021年,实验室测试领域占据最大市场份额,成像领域预计在预测期内将实现更高的复合年增长率。
基于实验室测试,市场分为血液测试和生物标记物。 2021年,血液检测细分市场占据更大的市场份额,预计该细分市场在预测期内的复合年增长率最高。
基于对于最终用户,市场分为医院和诊断实验室、学术和研究机构以及 CRO 实验室。 2021年,医院和诊断实验室细分市场占据最大市场份额,预计该细分市场在预测期内将实现更高的复合年增长率。
基于从国家来看,南美肝癌诊断市场分为巴西、阿根廷和南美其他地区。 2021年,巴西占据最大的市场份额,预计阿根廷在预测期内将以最快的复合年增长率增长。
雅培;生物梅里埃公司; F. 霍夫曼拉罗什有限公司;照明公司;皇家飞利浦公司;凯杰;西门子医疗股份公司;赛默飞世尔科技有限公司;通用电气医疗保健;和 Perspectum 是南美肝癌诊断市场的领先公司。
Strategic insights for South America Liver Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 626.52 Million |
Market Size by 2028 | US$ 1,025.70 Million |
Global CAGR (2021 - 2028) | 7.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South America Liver Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South America Liver Cancer Diagnostics Market is valued at US$ 626.52 Million in 2021, it is projected to reach US$ 1,025.70 Million by 2028.
As per our report South America Liver Cancer Diagnostics Market, the market size is valued at US$ 626.52 Million in 2021, projecting it to reach US$ 1,025.70 Million by 2028. This translates to a CAGR of approximately 7.3% during the forecast period.
The South America Liver Cancer Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Liver Cancer Diagnostics Market report:
The South America Liver Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Liver Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Liver Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.